Level VI lymph node dissection for papillary thyroid cancer.

Level VI lymph node dissection for papillary thyroid cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Level VI lymph node dissection for papillary thyroid cancer. Abstract Text:

M L White,G M Doherty,M L White,G M Doherty,

Papillary thyroid cancer (PTC) is the most common endocrine malignancy and commonly metastasizes to regional lymph nodes. Surgical treatment of cervical lymph nodes in PTC remains controversial. It has traditionally been accepted that regional lymph node metastases in PTC may increase local recurrence rates but do not ultimately affect survival. This conventional wisdom has been challenged by recent reports indicating that regional lymph node metastases do increase mortality. Thus, there has been renewed interest in operative control of nodal disease for PTC. A systematic review of central lymph node dissection (CLND) in the recent literature using evidence-based criteria permitted formation of the following five recommendations: 1) limited data suggest benefit with the addition of prophylactic CLND to thyroidectomy (grade C); 2) systematic compartment-oriented CLND may decrease recurrence of PTC and improve disease-specific survival (no grade); 3) the addition of CLND to total thyroidectomy can significantly reduce levels of serum thyroglobulin and increase rates of athyroglobulinemia (no grade); 4) there may be a higher rate of permanent hypopara-thyroidism and unintentional permanent nerve injury when CLND is performed with total thyroidectomy than for total thyroidectomy alone (grade C); 5) reoperation in the central neck compartment for recurrent PTC may increase the risk of hypoparathyroidism and unintentional nerve injury when compared to total thyroidectomy with or without CLND, supporting a more aggressive initial operation by experienced endocrine surgeons (grade C). Taken together, these recommendations support the application of routine CLND at the initial operation for papillary thyroid cancer in expert hands.

Level VI lymph node dissection for papillary thyroid cancer. Publishing Authors By Initials

ML White,GM Doherty,ML White,GM Doherty,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Level VI lymph node dissection for papillary thyroid cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Minerva chirurgica

VOLUME: 62

Page Numbers: 383-93

Journal Abbreviation:

ISSN: 0026-4733

DAY: 19

MONTH: Oct

YEAR: 2007

Level VI lymph node dissection for papillary thyroid cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 400726

Level VI lymph node dissection for papillary thyroid cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Level VI lymph node dissection for papillary thyroid cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Level VI lymph node dissection for papillary thyroid cancer.

AFFILIATION: Department of Surgery, University of Michigan, Ann Arbor, MI, USA gerardd@umich.edu.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Minerva Chir

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Level VI lymph node dissection for papillary thyroid cancer Related Publications

• A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.
• A randomized, placebo-controlled trial of preoperative oral pregabalin for postoperative pain relief after minor gynecological surgery.
• Acute alcohol intake impairs lung inflammation by changing pro- and anti-inflammatory mediator balance.
• Admission of error?
• Bioterrorism and biologic warfare.
• CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
• Concurrent sexual partnerships among men in the United States.
• Correction of the peripheral spatiotemporal response pattern: a potential new signal-processing strategy.
• Could we care for Amillia in rural Australia?
• Creatine monohydrate and conjugated linoleic Acid improve strength and body composition following resistance exercise in older adults.
• Development of a standardized medication assistant curriculum.
• Differential Affects of Interventions on Gait and Balance among People with Peripheral Neuropathy: 1655: Board #145 May 30 2:00 PM - 3:30 PM.
• Disregulated influenza A virus-specific CD8+ T cell homeostasis in the absence of IFN-gamma signaling.
• Effects of ketamine and magnesium on the minimum alveolar concentration of isoflurane in goats.
• Establishing priorities for national communicable disease surveillance.
• Fungous infections of the skin and scalp; a new approach to their treatment.
• Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses.
• Level VI lymph node dissection for papillary thyroid cancer.
• Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory.
• Nonhomologous end-joining in bacteria: a microbial perspective.
• Oral and Maxillofacial Injuries Experienced in Support of Operation Iraqi Freedom I and II.
• Screening pesticides for neuropathogenicity.
• Sweat And Core Temperature Responses In Professional Women's Tennis During Tournament Play In The Heat: 575: May 30 1:45 PM 2:00 PM.
• The control of attention to faces.
• The effect of prior bisphosphonate exposure on the treatment response to teriparatide in clinical practice.
• The latest in trauma nursing.
• Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity.
• Use of glass irrigator for anterior chamber.
• Validation of a self-report instrument for assessment of hallux valgus.
• [Assessing the prognosis in patients with chronic obstructive pulmonary disease]